An Integrated Population Pharmacokinetic Analysis to Characterize Levonorgestrel Pharmacokinetics After Different Administration Routes-Reference-Cited by-同舟云学术

An Integrated Population Pharmacokinetic Analysis to Characterize Levonorgestrel Pharmacokinetics After Different Administration Routes

Published:2018-09-12 Issue:12 Volume:58 Page:1639-1654
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Reinecke Isabel¹,Hofmann Birte²,Mesic Emir³,Drenth Henk-Jan³,Garmann Dirk⁴

Affiliation:

1. Clinical Pharmacometrics; Bayer AB, Solna, Sweden, on behalf of Bayer AG; Berlin Germany

2. Clinical Pharmacokinetics; Bayer AG; Berlin Germany

3. LAP&P Consultants BV; Leiden The Netherlands

4. Clinical Pharmacometrics; Bayer AG; Wuppertal Germany

Funder

Bayer AG

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcph.1288/fullpdf

Reference53 articles.

1. Implantable contraceptives for women;Meirik;Hum Reprod Update,2003

2. International Federation of Gynecology & Obstetrics (FIGO) International Consortium for Emergency Contraception - Joint Statement Mechanism of action: How do levonorgestrel-only emergency contraceptive pills (LNG ECPs) prevent pregnancy? 2011 http://www.figo.org/news/new-download-mechanism-action-how-do-levonorgestrel-only-emergency-contraceptive-pills-lng-ecps

3. Levonorgestrel-releasing intrauterine systems for long-acting contraception: current perspectives, safety, and patient counseling;Costescu;Int J Womens Health,2016

4. Levonorgestrel. Clinical pharmacokinetics;Fotherby;Clin Pharmacokinet,1995

5. Pharmacokinetics of levonorgestrel in 12 women who received a single oral dose of 0.15 mg levonorgestrel and, after a washout phase, the same dose during one treatment cycle;Kuhnz;Contraception,1992

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progestogen-Only Contraception;Textbook of Contraception, Sexual and Reproductive Health;2024-01-25

2. The effect of hormonal contraception on the risk of breast cancer: A review;Journal of Modern Oncology;2023-08-10

3. Extended use of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg: A population pharmacokinetic approach to estimate in vivo levonorgestrel release rates and systemic exposure including comparison with two other LNG-IUSs;Contraception;2023-04

4. Levonorgestrel intrauterine system and breast cancer risk: An updated systematic review and meta-analysis of observational studies;Heliyon;2023-04

5. Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case–control study and meta-analysis;PLOS Medicine;2023-03-21